We found 706 records for "Clinical research"

Articles

Does real world evidence matter in Health Technology Assessments?

27th January 2015

 Does real world evidence matter in Health Technology Assessments?Articles

Health Technology Assessment (HTA) agencies usually rely on randomised controlled trials for clinical data when evaluating drugs, but these do not always tell the entire story. Both biopharmaceutical companies and...

Read more

Ethics and the public good: the race to find a treatment for Ebola

20th January 2015

 Ethics and the public good: the race to find a treatment for EbolaArticles

With world attention focused on the Ebola outbreak, debate continues about whether experimental treatments should be given to patients when no other option exists. Leanne Orchard examines the implications of...

Read more

Real world evidence for pricing and reimbursement: the potential of Systemic Anti-Cancer Therapy (SACT) data

14th January 2015

 Real world evidence for pricing and reimbursement: the potential of Systemic Anti-Cancer Therapy (SACT) dataArticles

The difference between how a drug works in trials and how it works in a real world setting can be large. Now that NHS Trusts in England are providing SACT...

Read more

Healthcare perspectives: promoting innovation in the NHS

14th January 2015

 Healthcare perspectives: promoting innovation in the NHS Articles

pharmaphorum spoke to Tom Lindley, the head of Commercial Development at Yorkshire and Humber Academic Health Science Network, about the organisation and how it is pushing forward innovation in the...

Read more

News

£14m boost to stratified medicine research

29th January 2015

 £14m boost to stratified medicine researchNews

Stratified medicine collaborations in the UK are set to benefit from a further £13.7 million cash injection from the Medical Research Council (MRC) to investigate cancer, heart disease, asthma and...

Read more

Amgen riding high on 2014 results

29th January 2015

 Amgen riding high on 2014 resultsNews

Amgen has announced a rise in Q4 revenues of 6 per cent, with full-year revenues increasing 7 per cent to $20.1 billion, based on strong performances from Enbrel and across...

Read more

Momentum building behind tau as Alzheimer's target

28th January 2015

 Momentum building behind tau as Alzheimer's targetNews

After years of playing second fiddle to amyloid as a drug target in Alzheimer's disease, there are signs of increasing interest in the development of tau protein-targeting drugs.Earlier this month,...

Read more

Genzyme extends Gaucher disease options in Europe

26th January 2015

 Genzyme extends Gaucher disease options in EuropeNews

The European Commission (EC) has granted marketing authorisation for Genzyme's orphan drug Cerdelga (eliglustat), a first-line oral therapy for adults living with Gaucher disease type 1 (GD1).The drug was licensed...

Read more

White Papers

Giving a voice to those with heart valve disease

11th November 2014

 Giving a voice to those with heart valve diseaseWhite Papers

Although over a million people in the UK today have heart valve disease, it remains an overlooked condition. Despite the priority being given to cardiovascular disease in the UK, it...

Read more

Opportunities and challenges around non-adherence and self‑management in diabetes

3rd October 2014

 Opportunities and challenges around non-adherence and self‑management in diabetesWhite Papers

Diabetes is a chronic condition, the prevalence of which has been escalating around the world for years. The significant consequences this has for healthcare budgets and patient wellbeing is well...

Read more

Connected data and the use of smartphone enabled apps in market research

11th July 2014

 Connected data and the use of smartphone enabled apps in market researchWhite Papers

Rapid growth in smartphone usage offers healthcare researchers a useful tool to gain better understanding of how patients and healthcare professionals actually behave on a daily basis. Inaccuracies can arise...

Read more

Personalised Medicine – the Future of Blockbuster Pharma?

29th October 2013

 Personalised Medicine – the Future of Blockbuster Pharma?White Papers

The personalised medicine approach is rapidly becoming the new norm for pharmaceutical industry drug development and commercialisation, but it demands much more forward-thinking decision-making, as Phenestra outlines in its latest...

Read more

Audio & Video

Executive Perspectives: Jane Griffiths

  In the latest in our series of interviews with senior executives who are steering the global pharma industry through a period of unparalleled change, pharmaphorum speaks with Jane Griffiths, Company...

Read more

Full round table: Oncology shaping the future of personalised healthcare

  Watch the full round table video debate on 'oncology shaping the future of personalised healthcare', to see what our expert panel, with representation from pharma, diagnostics, physicians and patients, think...

Read more

Events

The Biologics Congress

2nd February 2015 - 3rd February 2015

The Biologics Congress

The Biologics market is evolving with the development of new products and therapies and is expected to hit $200 billion in the next few years. With growing commercial potential, good...

Read more

Disruptive Innovations Europe

10th February 2015 - 11th February 2015

Disruptive Innovations Europe

Welcome to DPharm Europe. We are delighted to take the only event dedicated to disruptive innovations to advance clinical trials to Europe. Event History It was a daunting task to develop the first...

Read more

Advances & Progress in Drug Design

16th February 2015 - 17th February 2015

Advances & Progress in Drug Design

SMi are proud to present the 14th annual conference, Advances and Progress in Drug Design, taking place on 16th & 17th February 2015 in Central London. Join us as we ask...

Read more

Patient Recruitment and Retention Summit

17th February 2015 - 19th February 2015

Patient Recruitment and Retention Summit

Pharmaceutical companies are facing a competitive atmosphere, increasing costs and a necessity to keep up with the fast-changing environment. Clearly, these factors also influence the clinical trials that represent a...

Read more

Press Releases

Clinical Professionals Group Launches Graduate Training Academy

16th October 2014

Clinical Professionals Group Launches Graduate Training Academy

The Clinical Professionals Group is known for their innovation and added value services to Life Sciences and is delighted to announce the launch of their unique Life Sciences Graduate Academy. With...

Read more

Reality medicine: How payers, regulators and pharma are working with real-world data

23rd September 2014

Reality medicine: How payers, regulators and pharma are working with real-world data

Real-world data (RWD) is creating an entirely new dimension to the evidence base for medicines that will be a critical component in how healthcare dollars are spent. Payers, regulators and...

Read more

Gower's latest Pharmaceutical and Healthcare Industry Catalogue

18th September 2014

Gower's latest Pharmaceutical and Healthcare Industry Catalogue

The latest Gower Pharmaceutical and Healthcare Industry Books Catalogue is now available online! Expanding on the Pharma and Health content this year, we have added details of books from our Governance & Leadership...

Read more

Inspire Community to Surpass Milestone of 500,000 Members

30th June 2014

Inspire Community to Surpass Milestone of 500,000 Members

SAN DIEGO, CA--(Marketwired - Jun 16, 2014) - Inspire, the social network for health, is about to reach the 500,000 member milestone. Inspire CEO Brian Loew announced the news today at...

Read more